SKAN AG / CH0013396012

Ad hoc announcement pursuant to Art. 53 LR
Allschwil, September 1, 2025 – SKAN Group announces that the Board of Directors completed the strategic succession planning process for the CEO position with the appointment of Jonas Greutert as of January 1, 2026. The Board of Directors expressed its sincere thanks to CEO Thomas Huber, who significantly and sustainably grew the company over eight consecutive years. Beat Lüthi, Chairman of the Board of SKAN Group, stated: “On behalf of the Board and all employees, I extend our sincere gratitude to Thomas Huber for his outstanding leadership. Under Thomas' guidance, SKAN Group has become the global market leader in high-quality isolator systems for aseptic production processes in the pharmaceutical and biotechnology industries. During his tenure, the company has seen significant revenue growth, expanded its international presence, and strengthened the high-margin Services & Consumables segment. We are pleased that Thomas Huber will remain actively involved as a Board member and continue to contribute with his knowledge and experience.” Jonas Greutert said: “I am honored and excited to join the SKAN Group. Thomas has built an impressive business and company culture. I look forward to building on this solid foundation with the team, continuing the success story by focusing on business growth, enhancing profitability, driving innovation, and creating value for our partners and customers.” Jonas Greutert has successfully led the Product Inspection Division at Mettler-Toledo since 2020. Prior to that, he held several senior international management roles within Mettler-Toledo from 2015 to 2020 and spent seven years in leadership positions at the Dätwyler Group. He holds a Diploma in Electrical Engineering and a Doctor of Computer Science from ETH Zurich, as well as an MBA from the University of Rochester, New York. Beat Lüthi added: “With Jonas Greutert, we gain a proven industry expert with many years of leadership experience in the relevant fields for the SKAN Group. Jonas Greutert has demonstrated that he can maintain a business in the pharmaceutical technology and industrial automation sector on a growth trajectory, increase profitability, and open up additional revenue sources. His entrepreneurial mindset and personal qualities align perfectly with our company culture, ensuring a smooth transition and a successful implementation of the strategic plans of the SKAN Group”   Contacts: Thomas Balmer, ir@skan.com, +41 79 703 87 28
Alexandre Müller, ir@skan.com, +41 79 635 64 13
Financial calendar:

24 March 2026	Publication Annual Results 2025
7 May 2026	Annual General Meeting 2026

  SKAN – together always one step ahead SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing processes for the (bio)pharmaceutical industry. The company is the market and technology leader for high-quality, process-critical isolator systems for filling drugs according to strict sterility standards. In addition, the company offers its customers process support, services and consumables. Innovative solutions and an efficient life-cycle support organisation make SKAN an important partner for the pharmaceutical and biotech industry, CMOs (Contract Manufacturing Organisations) and research laboratories worldwide. Founded in 1968, SKAN today employs more than 1600 people. More than half of them work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The other employees are located among the subsidiaries in Switzerland, Germany, Belgium, France, Slovenia, Japan, the USA and Brazil.